Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
nope, that's new as of this week. I checked last week and it still said June 1st. Again, where is the PR update and info surrounding this?
I think all longs understand what Senti is saying. What I don't understand is how you can go months without a PR or saying anything while we get pummeled again. Anyone who has run a company, including myself, knows that a story like this needs to be a campaign, not a one-time shot in the dark at ASCO. Seems LP was hoping this would just take on a life of its own. This should have been a three-to-four month campaign of news drips, starting with Publication, then ASCO, then as much info as they can weekly or every other week until we get 2018 refresh or unblinding in August (or whatever the plan is). The uncertainty and silence is what is killing us. SEC cannot prevent the company from issuing PR's with projections, plans, info...all subject to change but at least out there. Beyond frustrating, IMO.
I have honestly NEVER seen good news after such a news drought. It wreaks of incompetence and fear. 5+ weeks since ASCO, and nothing? The flop of a journal publication and little to no follow up by the company to get the word out. I'm sorry, if LP/LindaL/les/bosch who created and have been following these trials for over ten years and see the results form the journal article and are not screaming from the rooftops? And you wonder about the share price drop?
Another start to a week and nothing but the same speculation and rehashing expert analysis of blinded data prospects. And, the stock fading lower. “Coming weeks” was five weeks ago. I’d like that PR job, you don’t have to do anything. Chris L? August 18th is his guess for top line. November for others. LP needs to serve the shareholders who have funded her efforts and bought more stock as it got bashed. She needs a Trump-like PR and social media campaign to get the word out, and get the shorts out. The silence is killing us, regardless of some master plan she may have. It’s almost criminal, IMO.
i'm not buying this. OTCmarkets shows pink current with the QB symbol. I don't believe anything has changed. It is not listed under tier/symbol changes or name changes.
so, my stock is still trading on etrade as NWBOQB? Is that a different symbol?
two and a half weeks since ASCO and after NWBO said they will release info on "business dealings." Nothing, oh, another loan to get through June. WHERE is the news?????
Agreed. I am 100% behind this company and potential. I am also a business owner, sales person, and marketer. So, being frustrated is not negative. I honestly cannot imagine a company being so backwards in their PR approach. Where are the follow up interviews on TV? Stop saying the results "could get worse." Start shouting from the rooftop. That is, if you have the confidence in efficacy....that's what I would do and take my chances with SEC/FDA/NICE/Shorters.
bingo...
I agree that the ASCO fiasco did not build enthusiasm enough to move the stock so they could cash in on the warrants. Obviously LP thought it would too. Now, a crappy kick-the-can loan until when? It is about time, with known data in hand, and unblinded on the way, to create a media/investment buzz of epic proportion. And yet, crickets....that's the frustration. Say something, take a risk, compare NWBO to five other companies with less promising trials and compare the market caps....we need a short squeeze on a 50 million share day and all will be right with the world...and future secured for patients.
yes, but scary that the move seems so controlled. In the past this has led to dilution announcements only to drop to below the giveaway price!
There is no reason, IMO, that we shouldn't at least be at a new high 52 week high at this point. First look at blinded data looks promising, anticipation of more news and unblinding in the air, charts look good. And, anyone who really thinks shorting this stock at this point makes sense is unbalanced in their risk reward scenarios.
One thought I have for where we are and with all the speculation post ASCO is: NWBO pushed the combo trial start date out to June 1st from january 1st. Why? They obviously were hoping for the publication and blinded data out sooner, IMO. And, if BMY were a potential suitor, they would have moved forward with the combo trial sooner. So, again, IMO, I believe there is someone else in the wings and there may be something in the combo trial agreement that prohibits other partnerships during the trial?
Two weeks since ASCO, any news today? Where are the business dealings they were going to announce? Where is this PR firm? Shouldn’t they be getting the word out on the publication and data and controlling the narrative? I just don’t get it.
It's frustration, and I have a decent share count. Opportunity cost is driving me crazy as I allocate here and WAIT, and watch other opportunities pass by. ARRY for one, another NWBO type company, recently announced phase 3 results, probably as good as NWBO and their stock rises, $3.7 billion market cap.....we need ours to get there.
business dealings announced in the coming few weeks. that is what was said at ASCO, yes? Based on the way the stock is moving, lower as usual, my opinion is that it must be dilution. Combo trial supposed to start in June, no word, nothing. Spring refresh 2018, nothing. August is everyone's guess for unblinding, but who knows. If we don't get news on a partnership, unblinded data, or early NICE/FDA approval, I'm out soon.
Sad day of trading again. Word is out everywhere, data is good, if not great. IMO, PPS reflecting anticipated dilution, again. I agree with earlier comments, if that is what is announced...another loan from LP, or a kick the can down the road financing, without major partnership news or something similar, we decline again until the next release of real topline data.
No one writing to me. However, I agree with sojo55, and I have been spreading the news and ASCO video. twitter, linkedin, everywhere I can. And, yes, I was trying to figure out where Chris got his June NICE approval estimate from so I found this on the NICE website.
From NICE website, moved review of DCVAX-L up? This is new, yes?
16 August 2017 As you will be aware, the Department of Health has asked NICE to conduct an appraisal of DCVax-L for treating newly diagnosed glioblastoma. Please note that following on from advice received from the company this appraisal has been rescheduled to align with latest regulatory expectations. Therefore, we now anticipate that the appraisal will begin during mid-June 2018 when we will write to you about how you can get involved. The deadline for submissions is expected in approximately mid-August 2018
Chris Lacoursier just posted 30 minutes ago: "EU NICE approval imminent"
????
I for one think the slap down today was due to another impending dilution. Probably some are in the know ahead of time, as usual. Probably another 20 million shares at .27 to kick the can down the road. Frustrating that this great news cannot move the stock. I would almost rather do a ten for one reverse and uplift. At least then we may get some bigger players investing and able to control the shorts better.
Sojo, This, IMO, should be more than a technical move. Unfortunately, we are not getting the publicity from this data release that I expected. I would have expected multiple days of 20+ million shares traded and a new 1 yr high at least.....the company HAS to be more valuable today than anytime last year, with or without dilution.
Big news, big volume. Either shorts trying last ditch effort before word spreads or conversions taking place? We should be at a high for year at this point. Certainly this has never looked better as an opportunity and yet it is not flying. The rest of the week should tell the tale, but for me, even with ALL available outstanding shares and converted warrants (900+ million?), a $2 stock price is reasonable. IMO.
When do we get the PR from NWBO? during the trading day or after? And, with more coverage through ASCO, shouldn't we be at a new high for the year, at least?
I think LP loaned another million as a stopgap until publication/ASCO. I believe she believes we will have a PR by then or publication, or both. That way, limiting dilution to higher prices......IMO
It says that abstracts will be announced and posted on the ASCO website may 16th? How do we know they haven’t submitted? It says late breaking abstracts will be announced during the conference. I also read the confidentiality policy and it restricts publication of submitted abstracts prior to the event, unless SEC rules override and mandate. Could we have one submitted?
I was just commenting on the 500 posts about the vote. I voted yes to 1 and 2, no to 3. This vote, however, is very similar to voting for the Republican Presidential candidate from New York State. It's your right, obligation, etc....but it won't change the outcome.
I can't believe all the debate over voting on this. Close-held management shares and institutional insiders have enough to carry this without retail investors. a No vote is simply a disgust vote against management, but it will not matter. The ONLY thing that matters is a f'in publication and data release. Anything positive on those two fronts will generate a 30+ million share trading day and blow through the lower resistance levels into the .50's, from there who knows. Without such releases, we sit here and likely drift down.
The frustration is at the highest level for long term longs, and the "i told you so" is at an all time high for the shorts and naysayers. Chris L reads this board, Les and Linda must get as well, or get calls and anger from shareholders. And yet, Nothing, absolutely nothing but creative vagueness (imminent, publication, home run) while diluting the company shareholders. This meeting to increase shares without news is despicable. if there isn't positive news by Thursday, I think this goes to a nickel. Blind faith is for higher powers, not Linda Powers.
I agree with your voting strategy. We need more shares unfortunately, but the BOD and employees do not need to get options until we have news. If that's too late and they get less at higher prices, then so be it.
Maybe NWBO can set up individual consultation tables in the 4800sqft worth of booths they reserved at ASCO and answer all of these concerns. if not, they will be used as extra tables for lunch since they are across from the food court.
I hate trading on gut instinct, but I bought another 20,000 this morning. Too many conflicting rationales for what is going on. I see a technical opportunity in the short term to lower my cost average on 250,000 shares. I also believe in the science, just hope its not another hurry up and wait scenario come ASCO. One way or another they HAVE to announce results at some point. Good, bad or indifferent, I'm in until I see those results.
where did sojo55 go? Looking for a technical bottom and entry point!
From Chris on twitter:
"Great post on #ihub $NWBO investors need to realize @NorthwestBio is working closely with KOLs and #FDA on timing of WHEN to unblind #biotech #Biotechnology I believe we hear a great update prior #ASCO18"
Is he delusional or pumping? or Both? There is no corporate leadership. if I were the SEC I would be asking questions as well. Unblinded top line data imminent? Last September. 8 months ago. that's Criminal if spoken to pump to raise capital. Need data release NOW.
I get that. But there is other info they have and can share. Number still alive? They know that monthly, yes? General plans? We are hoping to get shareholders information on spring data refresh and publication info prior to the share increase vote? Anything!
Exactly my feeling...F'in say something. they have info they can share and they choose not to. And yet they expect all patient longs to accept more stock crammed down their throats and just sit there and take it.
Unbelievable. Who has the time to bother to short a one cent stock? There is very little upside and if this ever pops a few cents they would get crushed.
I have been in and out of this stock for three years. I think this is a bit fluffy as far as a release. They should say, based on where they are now, what the pro forma number look like for commercialization:
1. After 1000 hours it costs x to replace and refresh the unit
2. At current capacity, the unit will produce x kg of hydrogen daily and fill x number of cars.
3. A facility with 10 units can successfully fill x number of cars at the equivalent of x$ per gallon...
something that starts to make commercial business sense so people and investors can understand it.
It would be easy for the company to get a yes vote on share increase and end all the speculation if they would (and they CAN):
1. Tell us how many people are still alive. No update on this since the Fall, and they know this number
2. Tell us that they didn't set a specific date in April for the share increase vote because they will release any info on the spring refresh of data OR that they are waiting for the publication release, which will be ___________.
either of these will at least show they are trying to keep investors informed.
I personally believe in the science. I also agree that once top line announced they will have an exit strategy in place. I do not see them going it alone financially. If LP believes in the science and truly wants to help GBM and other cancers quickly, she would sell. She would make enough money in a buyout without getting greedy and making cancer patients wait.